One of the study's most significant findings was that patients managed using the advanced AI software saw LDL cholesterol drops of 18.7 mg/dL, with a 15% reduction in their risk of a cardiac event. Even patients with no calcified plaque saw significant changes in care management.

American Society of Echocardiography President David H. Wiener, MD, said one of his biggest goals is to help the group thrive in the face of ongoing workforce challenges. He also hopes to get new members involved.

The first FDA-cleared AI model of its kind was found to be an accurate screening tool for cardiac amyloidosis.

The use of advanced AI software to assess CCTA images continues to gain more momentum.

The new guidelines detail the use of echocardiography to evaluate patients for a variety of conditions.

New data suggest increases in CAC scores between lung cancer screenings strongly correlates with the risk of adverse cardiovascular events.

The model spots previously undetected scarring patterns on cardiac MRI scans of patients with hypertrophic cardiomyopathy—a leading cause of sudden cardiac death among young people.

A team of biomedical engineers, radiologists and cardiologists has developed a new AI model capable of restoring low-quality cardiac MRI scans.